Anti-CD4 Immunocytokine, IL2-IgG (OKT4) (ACFP-SH122)
This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-CD4 IgG to IL2. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the CD4 as well as the biological activity of IL2. IL2-FuP significantly accumulated in the tumor, which led to retardation of tumor growth. The fusion protein supported mainly proliferation and lymphokine-activated killer cell activity. The therapeutic effect was improved by intratumoral application. Importantly, the efficacy of both IL2-FuP depended on the induction of an immune response in vivo. This immunocytokine was designed for treating tumor.
Specifications
- Target
- CD4
- Molecule Class
- IL2-IgG
- Species Reactivity
- Human
- Host
- Mouse
- Expression Host
- CHO
- Clone
- OKT4
- Related Disease
- Tumor
- Cytokines 1
- IL2
- Cytokines 1 Description
- Interleukin-2 (IL-2) is an interleukin, a type of cytokine signaling molecule in the immune system. It is a protein that regulates the activities of white blood cells (leukocytes, often lymphocytes) that are responsible for immunity. IL-2 is part of the body's natural response to microbial infection, and in discriminating between foreign ("non-self") and "self". IL-2 mediates its effects by binding to IL-2 receptors, which are expressed by lymphocytes.
- Cytokine 1 Species
- Human
- Applications
- This product can be used therapeutically to deliver biologically active ligands to a desired tissue.
Target
- Alternative Names
- CD4; CD4 Molecule; T-Cell Surface Antigen T4/Leu-3; T-Cell Surface Glycoprotein CD4; CD4 Antigen; CD4mut; CD4 Receptor; CD4 Antigen (P55)
- Entrez Gene ID
- 920
- UniProt ID
- B4DT49
For lab research use only, not for diagnostic, therapeutic or any in vivo human use.
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email: